Apollo Endosurgery, Inc. (APEN)

NASDAQ: APEN · IEX Real-Time Price · USD
5.52 -0.15 (-2.65%)
Jan 19, 2022 9:48 AM EST - Market open
Market Cap218.00M
Revenue (ttm)59.68M
Net Income (ttm)-17.78M
Shares Out39.49M
EPS (ttm)-0.66
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume30,935
Open5.90
Previous Close5.67
Day's Range5.52 - 5.64
52-Week Range3.80 - 10.39
Beta2.20
AnalystsStrong Buy
Price Target13.33 (+141.5%)
Earnings DateNov 1, 2021

About APEN

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content em...

IndustryHealth Care Equipment & Supplies
Founded2005
CEOGary Atkinson
Employees158
Stock ExchangeNASDAQ
Ticker SymbolAPEN
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for APEN stock is "Strong Buy." The 12-month stock price forecast is 13.33, which is an increase of 141.49% from the latest price.

Price Target
$13.33
(141.49% upside)
Analyst Consensus: Strong Buy

News

Apollo Endosurgery Appoints Keely Scamperle as Vice President of Reimbursement and Market Access

Veteran Leader Brings 25 Years of Global Medical Device Experience AUSTIN, TX / ACCESSWIRE / January 18, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive m...

1 day ago - Accesswire

Down 21.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Apollo Endosurgery, Inc. (APEN)

Apollo Endosurgery, Inc. (APEN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analyst...

4 days ago - Zacks Investment Research

Apollo Endosurgery Announces Preliminary 2021 Revenue Results; Reflecting 50% Growth Over 2020

Fourth quarter 2021 revenue grew 25% over 2020 AUSTIN, TX / ACCESSWIRE / January 10, 2022 / Apollo Endosurgery, Inc. ("Apollo" or the "Company") (NASDAQ:APEN), a global leader in less invasive medical d...

1 week ago - Accesswire

Apollo Endosurgery, Inc. (APEN) Moves 7% Higher: Will This Strength Last?

Apollo Endosurgery, Inc. (APEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further pri...

2 weeks ago - Zacks Investment Research

Apollo Endosurgery Announces New $100 Million Senior Secured Term Loan Facility from Innovatus Capital Partners, LLC

$35 million funded at close to refinance existing debt, extend maturity and lower interest expense Additional borrowing capacity provides minimally dilutive growth capital and strategic flexibility AUST...

4 weeks ago - Accesswire

Apollo Endosurgery, Inc. (APEN) is on the Move, Here's Why the Trend Could be Sustainable

Apollo Endosurgery, Inc. (APEN) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed...

2 months ago - Zacks Investment Research

Apollo Endosurgery to Present at Four Upcoming Investor Conferences

AUSTIN, TX / ACCESSWIRE / November 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, toda...

2 months ago - Accesswire

Apollo Endosurgery, Inc. (APEN) Moves to Buy: Rationale Behind the Upgrade

Apollo Endosurgery, Inc. (APEN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

2 months ago - Zacks Investment Research

How Much Upside is Left in Apollo Endosurgery, Inc. (APEN)? Wall Street Analysts Think 35%

The consensus price target hints at a 35.4% upside potential for Apollo Endosurgery, Inc. (APEN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in ear...

2 months ago - Zacks Investment Research

Recap: Apollo Endosurgery Q3 Earnings

Apollo Endosurgery (NASDAQ:APEN) reported its Q3 earnings results on Monday, November 1, 2021 at 04:00 PM. Here's what investors need to know about the announcement.

2 months ago - Benzinga

Apollo Endosurgery, Inc. Reports 28% Revenue Growth in Third Quarter Conference Call and Webcast to Discuss Results T...

AUSTIN, TX / ACCESSWIRE / November 1, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today anno...

2 months ago - Accesswire

Apollo Endosurgery Announces Publication of a Multicenter Study of Its X-Tack(R)Endoscopic HeliX Tacking System

Study demonstrates high success rates, ease of use, and economic value in the treatment of GI defects AUSTIN, TX / ACCESSWIRE / November 1, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a gl...

2 months ago - Accesswire

Apollo Endosurgery's Earnings Outlook

Apollo Endosurgery (NASDAQ:APEN) is set to give its latest quarterly earnings report on Monday, 2021-11-01. Here's what investors need to know before the announcement.

2 months ago - Benzinga

Apollo Endosurgery to Report Third Quarter Financial Results on November 1, 2021

AUSTIN, TX / ACCESSWIRE / October 27, 2021 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal an...

2 months ago - Accesswire

Apollo Endosurgery Announces Positive MERIT-Trial Outcomes

Trial Results Demonstrate ESG Procedure Offers Significant and Durable Weight Loss, with Improvements in Obesity-Related Health Conditions MERIT-Trial met its primary endpoints for safety and efficacy, ...

2 months ago - Accesswire

Apollo Endosurgery Announces Closing of Public Offering and Exercise in Full of Option to Purchase Additional Shares

AUSTIN, TX / ACCESSWIRE / October 15, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced ...

3 months ago - Accesswire

Apollo Endosurgery Announces Pricing of $65 Million Public Offering of Common Stock

AUSTIN, TX / ACCESSWIRE / October 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced ...

3 months ago - Accesswire

Apollo Endosurgery Announces Commencement of Public Offering of Common Stock

AUSTIN, TX / ACCESSWIRE / October 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced ...

3 months ago - Accesswire

Apollo Endosurgery Announces Preliminary Third Quarter 2021 Financial Results and Provides Business Updates

Revenue expected between $16.0 million and $16.4 million Third consecutive quarter of double-digit revenue growth; endoscopic suturing up over 30% Submitted a De Novo 510(k) Classification Request to FD...

3 months ago - Accesswire

Apollo Endosurgery to Present at Lake Street's 5th Annual Best Ideas Growth Conference

AUSTIN, TX / ACCESSWIRE / September 13, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today an...

4 months ago - Accesswire

Apollo Endosurgery, Inc. (APEN) Reports Q2 Loss, Tops Revenue Estimates

Apollo Endosurgery, Inc. (APEN) delivered earnings and revenue surprises of 35.29% and 17.14%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

Apollo Endosurgery, Inc. Reports Record Endoscopy Revenue in Second Quarter, Raises Full-Year Outlook Conference Call...

AUSTIN, TX / ACCESSWIRE / August 3, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announ...

5 months ago - Accesswire

Will Apollo Endosurgery, Inc. (APEN) Report Negative Q2 Earnings? What You Should Know

Apollo Endosurgery, Inc. (APEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 months ago - Zacks Investment Research

Apollo Endosurgery to Report Second Quarter Financial Results on August 3, 2021

AUSTIN, TX / ACCESSWIRE / July 27, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric proc...

5 months ago - Accesswire

Apollo Endosurgery Appoints Jeffrey G. Black as Chief Financial Officer

Veteran Executive Brings 30 Years of Financial and Operational Leadership Experience AUSTIN, TX / ACCESSWIRE / July 16, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minim...

6 months ago - Accesswire